128 related articles for article (PubMed ID: 22985987)
1. Levels of human equilibrative nucleoside transporter-1 are higher in proliferating regions of A549 tumor cells grown as tumor xenografts in vivo.
Plotnik DA; Asher C; Chu SK; Miyaoka RS; Garwin GG; Johnson BW; Li T; Krohn KA; Schwartz JL
Nucl Med Biol; 2012 Nov; 39(8):1161-6. PubMed ID: 22985987
[TBL] [Abstract][Full Text] [Related]
2. Biodistribution and uptake of 3'-deoxy-3'-fluorothymidine in ENT1-knockout mice and in an ENT1-knockdown tumor model.
Paproski RJ; Wuest M; Jans HS; Graham K; Gati WP; McQuarrie S; McEwan A; Mercer J; Young JD; Cass CE
J Nucl Med; 2010 Sep; 51(9):1447-55. PubMed ID: 20720035
[TBL] [Abstract][Full Text] [Related]
3. Variability of Proliferation and Diffusion in Different Lung Cancer Models as Measured by 3'-Deoxy-3'-¹⁸F-Fluorothymidine PET and Diffusion-Weighted MR Imaging.
Schelhaas S; Wachsmuth L; Viel T; Honess DJ; Heinzmann K; Smith DM; Hermann S; Wagner S; Kuhlmann MT; Müller-Tidow C; Kopka K; Schober O; Schäfers M; Schneider R; Aboagye EO; Griffiths J; Faber C; Jacobs AH
J Nucl Med; 2014 Jun; 55(6):983-8. PubMed ID: 24777288
[TBL] [Abstract][Full Text] [Related]
4. Different modes of transport for 3H-thymidine, 3H-FLT, and 3H-FMAU in proliferating and nonproliferating human tumor cells.
Plotnik DA; Emerick LE; Krohn KA; Unadkat JD; Schwartz JL
J Nucl Med; 2010 Sep; 51(9):1464-71. PubMed ID: 20720049
[TBL] [Abstract][Full Text] [Related]
5. 3'-Deoxy-3'-[(18)F]-fluorothymidine ([(18)F]-FLT) transport in newly diagnosed glioma: correlation with nucleoside transporter expression, vascularization, and blood-brain barrier permeability.
Shinomiya A; Miyake K; Okada M; Nakamura T; Kawai N; Kushida Y; Haba R; Kudomi N; Tokuda M; Tamiya T
Brain Tumor Pathol; 2013 Oct; 30(4):215-23. PubMed ID: 23423309
[TBL] [Abstract][Full Text] [Related]
6. The role of nucleoside/nucleotide transport and metabolism in the uptake and retention of 3'-fluoro-3'-deoxythymidine in human B-lymphoblast cells.
Plotnik DA; McLaughlin LJ; Chan J; Redmayne-Titley JN; Schwartz JL
Nucl Med Biol; 2011 Oct; 38(7):979-86. PubMed ID: 21982569
[TBL] [Abstract][Full Text] [Related]
7. Visualization research on ENT1/NIS dual-function gene therapy to reverse drug resistance mediated by MUC1 in GEM-resistant pancreatic cancer.
Xi Y; Chen H; Xi Y; Hai W; Qu Q; Zhang M; Li B
Nucl Med Biol; 2023; 120-121():108350. PubMed ID: 37229950
[TBL] [Abstract][Full Text] [Related]
8. Effect of hypoxia on human equilibrative nucleoside transporters hENT1 and hENT2 in breast cancer.
Krys D; Hamann I; Wuest M; Wuest F
FASEB J; 2019 Dec; 33(12):13837-13851. PubMed ID: 31601121
[TBL] [Abstract][Full Text] [Related]
9. Correlation of 18F-FLT uptake with equilibrative nucleoside transporter-1 and thymidine kinase-1 expressions in gastrointestinal cancer.
Kameyama R; Yamamoto Y; Izuishi K; Sano T; Nishiyama Y
Nucl Med Commun; 2011 Jun; 32(6):460-5. PubMed ID: 21423062
[TBL] [Abstract][Full Text] [Related]
10. The effects of 5-fluoruracil treatment on 3'-fluoro-3'-deoxythymidine (FLT) transport and metabolism in proliferating and non-proliferating cultures of human tumor cells.
Plotnik DA; McLaughlin LJ; Krohn KA; Schwartz JL
Nucl Med Biol; 2012 Oct; 39(7):970-6. PubMed ID: 22560972
[TBL] [Abstract][Full Text] [Related]
11. Etoposide increases equilibrative nucleoside transporter 1 activity and fluorothymidine uptake: screening of 60 cytotoxic agents.
Lee EJ; Lee SJ
Oncol Rep; 2013 Feb; 29(2):763-70. PubMed ID: 23232555
[TBL] [Abstract][Full Text] [Related]
12. Thymidine phosphorylase influences [(18)F]fluorothymidine uptake in cancer cells and patients with non-small cell lung cancer.
Lee SJ; Yeo JS; Lee HJ; Lee EJ; Kim SY; Jang SJ; Lee JJ; Ryu JS; Moon DH
Eur J Nucl Med Mol Imaging; 2014 Jul; 41(7):1327-35. PubMed ID: 24562648
[TBL] [Abstract][Full Text] [Related]
13. Early detection of pemetrexed-induced inhibition of thymidylate synthase in non-small cell lung cancer with FLT-PET imaging.
Chen X; Yang Y; Berger I; Khalid U; Patel A; Cai J; Farwell MD; Langer C; Aggarwal C; Albelda SM; Katz SI
Oncotarget; 2017 Apr; 8(15):24213-24223. PubMed ID: 27655645
[TBL] [Abstract][Full Text] [Related]
14. Equilibrative Nucleoside Transporter 1 (ENT1,
Cerveny L; Ptackova Z; Ceckova M; Karahoda R; Karbanova S; Jiraskova L; Greenwood SL; Glazier JD; Staud F
Drug Metab Dispos; 2018 Nov; 46(11):1817-1826. PubMed ID: 30097436
[TBL] [Abstract][Full Text] [Related]
15. [Correlation of 3'-deoxy-3'-18F-fluorothymidine uptake to cell proliferation in lung carcinoma xenografts].
Liu X; Zhou NK; Zhang JM; Liang ZY; Zheng X
Ai Zheng; 2006 Dec; 25(12):1512-6. PubMed ID: 17166377
[TBL] [Abstract][Full Text] [Related]
16. 3'-Deoxy-3'-[18F]Fluorothymidine Positron Emission Tomography Depicts Heterogeneous Proliferation Pathology in Idiopathic Pulmonary Arterial Hypertension Patient Lung.
Ashek A; Spruijt OA; Harms HJ; Lammertsma AA; Cupitt J; Dubois O; Wharton J; Dabral S; Pullamsetti SS; Huisman MC; Frings V; Boellaard R; de Man FS; Botros L; Jansen S; Vonk Noordegraaf A; Wilkins MR; Bogaard HJ; Zhao L
Circ Cardiovasc Imaging; 2018 Aug; 11(8):e007402. PubMed ID: 30354494
[TBL] [Abstract][Full Text] [Related]
17. Demonstration of Nucleoside Transporter Activity in the Nose-to-Brain Distribution of [
Ponto LLB; Huang J; Walsh SA; Acevedo MR; Mundt C; Sunderland J; Donovan M
AAPS J; 2017 Dec; 20(1):16. PubMed ID: 29218445
[TBL] [Abstract][Full Text] [Related]
18. [18F]FLT PET for non-invasive assessment of tumor sensitivity to chemotherapy: studies with experimental chemotherapy TP202377 in human cancer xenografts in mice.
Munk Jensen M; Erichsen KD; Björkling F; Madsen J; Jensen PB; Sehested M; Højgaard L; Kjær A
PLoS One; 2012; 7(11):e50618. PubMed ID: 23226334
[TBL] [Abstract][Full Text] [Related]
19. Metabolism of 3'-deoxy-3'-[F-18]fluorothymidine in proliferating A549 cells: validations for positron emission tomography.
Grierson JR; Schwartz JL; Muzi M; Jordan R; Krohn KA
Nucl Med Biol; 2004 Oct; 31(7):829-37. PubMed ID: 15464384
[TBL] [Abstract][Full Text] [Related]
20. [(18)F]FLT-PET imaging does not always "light up" proliferating tumor cells.
Zhang CC; Yan Z; Li W; Kuszpit K; Painter CL; Zhang Q; Lappin PB; Nichols T; Lira ME; Affolter T; Fahey NR; Cullinane C; Spilker M; Zasadny K; O'Brien P; Buckman D; Wong A; Christensen JG
Clin Cancer Res; 2012 Mar; 18(5):1303-12. PubMed ID: 22170262
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
